(Q34609415)

3 August 2017

1 reference

title

Review article: COX-2, prostanoids and colon cancer (English)

1 reference

3 August 2017

1 reference

Ota S

1

1 reference

3 August 2017

Bamba H

2

1 reference

3 August 2017

Kato A

3

1 reference

3 August 2017

Kawamoto C

4

1 reference

3 August 2017

Yoshida Y

5

1 reference

3 August 2017

Fujiwara K

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

published in

1 reference

3 August 2017

volume

16 Suppl 2

1 reference

3 August 2017

page(s)

102-106

1 reference

Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

High expression of cyclooxygenase-2 in macrophages of human colonic adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Localization of cyclooxygenase-2 in human sporadic colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.8.X

10.1046/J.1365-2036.16.S2.8.X

21 January 2018

Identifiers

DOI

1 reference

release_rg7exxm4ojdljf5axf3vib7oqq

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rg7exxm4ojdljf5axf3vib7oqq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference